Dezhan Healthcare Company Limited (SHE:000813)
China · Delayed Price · Currency is CNY 3.480
+0.130 (3.88%)
Aug 20, 2026, 3:04 PM CST
Dezhan Healthcare Company Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 7,298 | 8,053 | 6,776 | 7,046 | 8,229 | 9,027 | |
Market Cap Growth | -15.74% | 18.84% | -3.82% | -14.38% | -8.83% | -8.13% |
Enterprise Value | 5,943 | 5,800 | 4,147 | 4,210 | 6,006 | 7,124 |
Last Close Price | 3.48 | 3.84 | 3.13 | 3.27 | 3.71 | 4.07 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | - | 84.57 | - | - |
Forward PE | - | 25.96 | 25.96 | 25.96 | 25.96 | 25.96 |
PS Ratio | 18.42 | 20.29 | 14.53 | 14.15 | 14.42 | 12.29 |
PB Ratio | 1.61 | 1.76 | 1.31 | 1.34 | 1.56 | 1.65 |
P/TBV Ratio | 1.73 | 1.89 | 1.44 | 1.48 | 1.69 | 1.85 |
P/FCF Ratio | - | - | - | - | 87.40 | - |
P/OCF Ratio | 2638.21 | 1705.22 | - | 55.10 | 50.89 | 212.85 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 15.00 | 14.62 | 8.89 | 8.45 | 10.52 | 9.70 |
EV/EBITDA Ratio | - | - | 13564.12 | 163.82 | - | 55.72 |
EV/EBIT Ratio | - | - | - | - | - | 143.13 |
EV/FCF Ratio | - | - | - | - | 63.79 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.03 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
Debt / EBITDA Ratio | - | - | 4.91 | 0.27 | - | 0.09 |
Debt / FCF Ratio | - | - | - | - | 0.10 | - |
Net Debt / Equity Ratio | -0.28 | -0.37 | -0.49 | -0.53 | -0.57 | -0.45 |
Net Debt / EBITDA Ratio | 11.50 | 17.07 | -8217.60 | -108.52 | 46.52 | -19.39 |
Net Debt / FCF Ratio | 4.64 | 7.27 | 13.87 | 87.54 | -31.75 | 29.34 |
Asset Turnover | 0.08 | 0.08 | 0.09 | 0.09 | 0.10 | 0.12 |
Inventory Turnover | 1.17 | 1.07 | 0.84 | 0.97 | 1.31 | 0.85 |
Quick Ratio | 15.27 | 15.27 | 28.53 | 34.13 | 11.02 | 12.79 |
Current Ratio | 16.69 | 16.48 | 30.50 | 36.41 | 11.82 | 14.24 |
Return on Equity (ROE) | -9.02% | -8.67% | -0.81% | 1.03% | -2.85% | -1.68% |
Return on Assets (ROA) | -2.41% | -2.23% | -0.94% | -0.63% | -1.67% | 0.51% |
Return on Invested Capital (ROIC) | -6.38% | -6.57% | -3.16% | -1.55% | -5.79% | 1.83% |
Return on Capital Employed (ROCE) | -4.20% | -3.90% | -1.50% | -1.10% | -2.90% | 0.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | -4.90% | -4.29% | -0.30% | 1.18% | -0.57% | -0.64% |
FCF Yield | -3.79% | -2.87% | -2.67% | -0.45% | 1.14% | -0.94% |
Payout Ratio | - | - | - | 0.03% | - | - |
Buyback Yield / Dilution | 1.56% | 1.56% | 1.48% | 1.52% | 1.15% | -0.95% |
Total Shareholder Return | 1.56% | 1.56% | 1.48% | 1.52% | 1.15% | -0.95% |